BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20607838)

  • 1. Pharmacogenetics of drug-induced liver injury.
    Russmann S; Jetter A; Kullak-Ublick GA
    Hepatology; 2010 Aug; 52(2):748-61. PubMed ID: 20607838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
    Aithal GP
    Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic basis of drug-induced liver injury: present and future.
    Urban TJ; Daly AK; Aithal GP
    Semin Liver Dis; 2014 May; 34(2):123-33. PubMed ID: 24879978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.
    Grove JI; Aithal GP
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):395-409. PubMed ID: 25491399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver injury: Interactions between drug properties and host factors.
    Chen M; Suzuki A; Borlak J; Andrade RJ; Lucena MI
    J Hepatol; 2015 Aug; 63(2):503-14. PubMed ID: 25912521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced liver injury: insights from genetic studies.
    Andrade RJ; Robles M; Ulzurrun E; Lucena MI
    Pharmacogenomics; 2009 Sep; 10(9):1467-87. PubMed ID: 19761370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced liver injury: past, present and future.
    Daly AK
    Pharmacogenomics; 2010 May; 11(5):607-11. PubMed ID: 20415545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced liver injury: what was new in 2013?
    Chalhoub WM; Sliman KD; Arumuganathan M; Lewis JH
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):959-80. PubMed ID: 24746272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic association studies in drug-induced liver injury.
    Daly AK; Day CP
    Semin Liver Dis; 2009 Nov; 29(4):400-11. PubMed ID: 19826974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latest advances in predicting DILI in human subjects: focus on biomarkers.
    Hawkins MT; Lewis JH
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1521-30. PubMed ID: 22998122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced liver injury: what was new in 2008?
    Liss G; Lewis JH
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):843-60. PubMed ID: 19505188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen Alleles.
    Nicoletti P; Aithal GP; Chamberlain TC; Coulthard S; Alshabeeb M; Grove JI; Andrade RJ; Bjornsson E; Dillon JF; Hallberg P; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Wadelius M; Shen Y; Nelson MR; Daly AK;
    Clin Pharmacol Ther; 2019 Jul; 106(1):245-253. PubMed ID: 30661239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic risk factors in the development of idiosyncratic drug-induced liver injury.
    Stephens C; Lucena MI; Andrade RJ
    Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):153-169. PubMed ID: 33222552
    [No Abstract]   [Full Text] [Related]  

  • 15. The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury.
    Amacher DE
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):335-47. PubMed ID: 22288564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?
    Shahbaz O; Mahajan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):935-951. PubMed ID: 28772086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).
    Pachkoria K; Lucena MI; Ruiz-Cabello F; Crespo E; Cabello MR; Andrade RJ;
    Br J Pharmacol; 2007 Mar; 150(6):808-15. PubMed ID: 17279092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts of mechanisms in drug-induced hepatotoxicity.
    Russmann S; Kullak-Ublick GA; Grattagliano I
    Curr Med Chem; 2009; 16(23):3041-53. PubMed ID: 19689281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly identified genetic variants associated with idiosyncratic drug-induced liver injury.
    Stolz A
    Curr Opin Gastroenterol; 2022 May; 38(3):230-238. PubMed ID: 35645018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.
    Fontana RJ
    Gastroenterology; 2014 Apr; 146(4):914-28. PubMed ID: 24389305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.